Stay updated on Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    The page now displays a recruitment status indicating no participants are being sought and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) to assist visitors. Additionally, the formatting of the Intervention/Treatment label was normalized from 'Intervention / Treatment' and the revision tag updated from v3.5.5 to v3.6.0.
    Difference
    0.4%
    Check dated 2026-06-12T16:28:45.000Z thumbnail image
  3. Check
    16 days ago
    Change Detected
    Summary
    The page’s revision tag was updated to v3.5.5, replacing the previous v3.5.4 tag.
    Difference
    0.1%
    Check dated 2026-06-05T13:30:34.000Z thumbnail image
  4. Check
    38 days ago
    Change Detected
    Summary
    Revision updated from v3.5.3 to v3.5.4 on the page. This appears to be a small metadata or formatting update and does not modify study details, eligibility criteria, or results.
    Difference
    0.1%
    Check dated 2026-05-15T06:55:26.000Z thumbnail image
  5. Check
    59 days ago
    Change Detected
    Summary
    The page’s ClinicalTrials.gov UI/version footer was updated from **v3.5.2** to **v3.5.3**, indicating a site revision rather than a change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:28:01.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Page revision updated from v3.5.0 to v3.5.2.
    Difference
    0.1%
    Check dated 2026-04-17T02:41:47.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    Added the related MeSH term 'Primary interstitial lung disease specific to childhood' to the page's related topics/MeSH terms.
    Difference
    0.1%
    Check dated 2026-04-02T15:35:41.000Z thumbnail image

Stay in the know with updates to Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Doxorubicin & Pembrolizumab in Sarcoma Clinical Trial page.